299 related articles for article (PubMed ID: 12738892)
1. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
Stroke; 2003 Jun; 34(6):1507-12. PubMed ID: 12738892
[TBL] [Abstract][Full Text] [Related]
2. Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
J Cereb Blood Flow Metab; 2004 Jan; 24(1):114-23. PubMed ID: 14688623
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
4. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
Li Q; Stephenson D
Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
[TBL] [Abstract][Full Text] [Related]
5. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
Pei Z; Pang SF; Cheung RT
Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation.
Eschenfelder CC; Krug R; Yusofi AF; Meyne JK; Herdegen T; Koch A; Zhao Y; Carl UM; Deuschl G
Cerebrovasc Dis; 2008; 25(3):193-201. PubMed ID: 18212507
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
Engelhorn T; Goerike S; Doerfler A; Okorn C; Forsting M; Heusch G; Schulz R
J Cereb Blood Flow Metab; 2004 Apr; 24(4):467-74. PubMed ID: 15087716
[TBL] [Abstract][Full Text] [Related]
8. Role of residual flow on the neuroprotective efficacy of human albumin in the rat with transient cerebral ischemia.
Chen J; Ji X; Ding Y; Luo Y; Cheng H; Ling F
Neurol Res; 2009 May; 31(4):396-401. PubMed ID: 19508826
[TBL] [Abstract][Full Text] [Related]
9. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats.
Zausinger S; Schöller K; Plesnila N; Schmid-Elsaesser R
Stroke; 2003 Sep; 34(9):2246-51. PubMed ID: 12893947
[TBL] [Abstract][Full Text] [Related]
10. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats.
Li F; Omae T; Fisher M
Stroke; 1999 Nov; 30(11):2464-70; discussion 2470-1. PubMed ID: 10548685
[TBL] [Abstract][Full Text] [Related]
12. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.
Schäbitz WR; Hoffmann TT; Heiland S; Kollmar R; Bardutzky J; Sommer C; Schwab S
Stroke; 2001 May; 32(5):1226-33. PubMed ID: 11340238
[TBL] [Abstract][Full Text] [Related]
13. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia.
Zhang Y; Wang L; Li J; Wang XL
J Pharmacol Exp Ther; 2006 Jun; 317(3):973-9. PubMed ID: 16527903
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
Zhang Y; Feustel PJ; Kimelberg HK
Brain Res; 2006 Jun; 1094(1):200-6. PubMed ID: 16709402
[TBL] [Abstract][Full Text] [Related]
15. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats.
Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R
Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594
[TBL] [Abstract][Full Text] [Related]
16. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
[TBL] [Abstract][Full Text] [Related]
17. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
Harrigan MR; Ennis SR; Sullivan SE; Keep RF
Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
[TBL] [Abstract][Full Text] [Related]
18. Steady plasma concentration of unfractionated heparin reduces infarct volume and prevents inflammatory damage after transient focal cerebral ischemia in the rat.
Cervera A; Justicia C; Reverter JC; Planas AM; Chamorro A
J Neurosci Res; 2004 Aug; 77(4):565-72. PubMed ID: 15264226
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat.
Vemuganti R; Dempsey RJ; Bowen KK
Stroke; 2004 Jan; 35(1):179-84. PubMed ID: 14657453
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen.
Zausinger S; Westermaier T; Plesnila N; Steiger HJ; Schmid-Elsaesser R
Stroke; 2003 Jun; 34(6):1526-32. PubMed ID: 12730554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]